Apollomics Inc. (APLM)
(Delayed Data from NSDQ)
$0.21 USD
+0.01 (2.65%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $0.20 -0.01 (-2.58%) 4:36 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Balance Sheet
Fiscal Year End for Apollomics Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 38 | 52 | 70 | 154 | -99,999 |
Receivables | 0 | 0 | 0 | 0 | NA |
Notes Receivable | 0 | 0 | 0 | 0 | NA |
Inventories | 0 | 0 | 0 | 0 | NA |
Other Current Assets | 2 | 4 | 29 | 3 | NA |
Total Current Assets | 40 | 56 | 99 | 158 | NA |
Net Property & Equipment | 0 | 0 | 0 | 0 | NA |
Investments & Advances | 0 | 0 | 0 | 0 | NA |
Other Non-Current Assets | 0 | 0 | 0 | 0 | NA |
Deferred Charges | 0 | 0 | 0 | 0 | NA |
Intangibles | 15 | 15 | 15 | 10 | NA |
Deposits & Other Assets | 0 | 4 | 8 | 0 | NA |
Total Assets | 55 | 76 | 123 | 170 | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | NA |
Accounts Payable | 0 | 0 | 0 | 0 | NA |
Current Portion Long-Term Debt | 4 | 0 | 0 | 0 | NA |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | NA |
Accrued Expenses | 0 | 0 | 0 | 0 | NA |
Income Taxes Payable | 0 | 0 | 0 | 0 | NA |
Other Current Liabilities | 9 | 12 | 13 | 11 | NA |
Total Current Liabilities | 14 | 12 | 14 | 12 | NA |
Mortgages | 0 | 0 | 0 | 0 | NA |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | NA |
Convertible Debt | 0 | 0 | 0 | 0 | NA |
Long-Term Debt | 0 | 0 | 0 | 0 | NA |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | NA |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | NA |
Minority Interest (Liabilities) | 0 | 512 | 322 | 285 | NA |
Total Liabilities | 14 | 525 | 336 | 298 | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | NA |
Common Stock (Par) | 0 | 0 | 0 | 0 | NA |
Capital Surplus | 661 | 12 | 12 | 12 | NA |
Retained Earnings | -647 | -475 | -235 | -142 | NA |
Other Equity | 27 | 14 | 12 | 5 | NA |
Treasury Stock | 0 | 0 | 2 | 3 | NA |
Total Shareholder's Equity | 41 | -448 | -213 | -128 | NA |
Total Liabilities & Shareholder's Equity | 55 | 76 | 123 | 170 | NA |
Total Common Equity | 41 | -448 | -213 | -128 | 0 |
Shares Outstanding | 86.80 | 13.40 | 3.00 | NA | NA |
Book Value Per Share | 0.48 | -33.44 | -70.95 | 0.00 | 0.00 |
Fiscal Year End for Apollomics Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | 38 | -99,999 | 46 |
Receivables | NA | NA | 0 | NA | NA |
Notes Receivable | NA | NA | 0 | NA | NA |
Inventories | NA | NA | 0 | NA | NA |
Other Current Assets | NA | NA | 2 | NA | 10 |
Total Current Assets | NA | NA | 40 | NA | 55 |
Net Property & Equipment | NA | NA | 0 | NA | 0 |
Investments & Advances | NA | NA | 0 | NA | NA |
Other Non-Current Assets | NA | NA | 0 | NA | NA |
Deferred Charges | NA | NA | 0 | NA | NA |
Intangibles | NA | NA | 15 | NA | 15 |
Deposits & Other Assets | NA | NA | 0 | NA | 0 |
Total Assets | NA | NA | 55 | NA | 71 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | NA | NA |
Accounts Payable | NA | NA | 0 | NA | 1 |
Current Portion Long-Term Debt | NA | NA | 4 | NA | NA |
Current Portion Capital Leases | NA | NA | 0 | NA | NA |
Accrued Expenses | NA | NA | 0 | NA | NA |
Income Taxes Payable | NA | NA | 0 | NA | NA |
Other Current Liabilities | NA | NA | 9 | NA | 13 |
Total Current Liabilities | NA | NA | 14 | NA | 14 |
Mortgages | NA | NA | 0 | NA | NA |
Deferred Taxes/Income | NA | NA | 0 | NA | NA |
Convertible Debt | NA | NA | 0 | NA | NA |
Long-Term Debt | NA | NA | 0 | NA | NA |
Non-Current Capital Leases | NA | NA | 0 | NA | NA |
Other Non-Current Liabilities | NA | 0 | NA | 1 | |
Minority Interest (Liabilities) | NA | NA | 0 | NA | NA |
Total Liabilities | NA | NA | 14 | NA | 16 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | NA | NA |
Common Stock (Par) | NA | NA | 0 | NA | 0 |
Capital Surplus | NA | NA | 661 | NA | 661 |
Retained Earnings | NA | NA | -647 | NA | -625 |
Other Equity | NA | NA | 27 | NA | 19 |
Treasury Stock | NA | NA | 0 | NA | NA |
Total Shareholder's Equity | NA | NA | 41 | NA | 56 |
Total Liabilities & Shareholder's Equity | NA | NA | 55 | NA | 71 |
Total Common Equity | 0 | 0 | 41 | 0 | 100,055 |
Shares Outstanding | 89.50 | 89.50 | 86.80 | 86.80 | 86.80 |
Book Value Per Share | 0.00 | 0.00 | 0.48 | 0.00 | 1,152.70 |